Analystreport

Vanda Pharmaceuticals (NASDAQ:VNDA) was upgraded by analysts at B. Riley to a "strong-buy" rating.

Vanda Pharmaceuticals Inc.  (VNDA) 
Last vanda pharmaceuticals inc. earnings: 2/25 04:01 pm Check Earnings Report